Evidence map›Paper›PMID 33491834›Full record

ArticleEuropean journal of cancer care2021

Treatment decision-making and the added value of the general practitioner: A qualitative exploration of cancer patients' perspectives.

Eveline A Noteboom, Sigrid C J M Vervoort, Anne M May, Eleonora B L van Dorst, Anne S R van Lindert, Maarten W van Elst, Rhodé M Bijlsma, Elsken van der Wall, Niek J de Wit, Charles W Helsper

Open access · hybridAbstract read
In one paragraph

Article in European journal of cancer care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Eveline A NoteboomJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0001-5044-5591
Sigrid C J M VervoortDepartment of Innovation in Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Anne M MayJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Eleonora B L van DorstDepartment of Gynaecologic Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Anne S R van LindertDepartment of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
Maarten W van ElstDepartment of Urologic Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Rhodé M BijlsmaDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Elsken van der WallDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Niek J de WitJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-0273-8290
Charles W HelsperJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-3268-174X
University Medical Center Utrecht · NLUtrecht University · NL

Funding

Danone Ecosystem FundKWF Kankerbestrijding
6 · The paper itself

Abstract

objectiveCancer patients are increasingly involved in decision-making for cancer treatment. General practitioners' (GPs) support in this process is advocated. Therefore, GPs need to be aware of patients' treatment decision-making process and their potential role. We aim to understand the treatment decision-making process and to explore the added value of GP involvement, from the perspective of cancer patients treated with curative intent.

methodsAn explorative qualitative study was performed. Semi-structured interviews were conducted with 20 purposively sampled Dutch cancer patients treated with curative intent.

resultsPatients' treatment decision-making process was dominated by a focus on 'safeguarding survival'. Patients generally followed the treatment plan as proposed by their physician and did not always experience having a treatment choice. The majority of patients expressed added value for GP involvement, mainly to provide psychological support, but also for providing shared decision-making (SDM) support.

conclusionThe treatment decision-making process of cancer patients treated with curative intent is dominated by the urge to 'safeguard survival'. GPs should be aware of their added value in providing psychological support and their potential role to support SDM following a cancer diagnosis.

Indexed as

Decision MakingGeneral PractitionersNeoplasmsPhysician-Patient RelationsAgedFemaleHumansMaleMiddle AgedPatient ParticipationQualitative Researchdecision-makinggeneral practicegeneral practitionersmedical oncologyneoplasmspatient preference

Identifiers

PMID33491834
PMCPMC8243976
OpenAlexW3125036323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.